Document Detail

Clinical pharmacology as a cornerstone of orphan drug development.
MedLine Citation:
PMID:  22037026     Owner:  NLM     Status:  In-Data-Review    
A recent US Food and Drug Administration (FDA) advisory committee meeting highlighted the potential of clinical pharmacology to overcome challenges in orphan drug development.
Edward D Bashaw; Shiew-Mei Huang; Timothy R Coté; Anne R Pariser; Christine E Garnett; Gilbert Burckart; Lei Zhang; Angela Y Men; Christine D Le; Rosane Charlab; Jogaro V Gobburu; Lawrence J Lesko
Related Documents :
23498046 - Inhaled anesthetics in horses.
21701616 - Clinical safety and tolerability issues in use of triazole derivatives in management of...
22026526 - Epidemiological characterization of drug overconsumption: the example of antidepressants.
22131696 - Micro-organisms in vedas.
17948616 - Oral anticoagulation: preparing for change.
1499716 - Intraventricular rifampicin in severe tuberculous meningo-encephalitis.
Publication Detail:
Type:  Journal Article     Date:  2011-10-31
Journal Detail:
Title:  Nature reviews. Drug discovery     Volume:  10     ISSN:  1474-1784     ISO Abbreviation:  Nat Rev Drug Discov     Publication Date:  2011  
Date Detail:
Created Date:  2011-10-31     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101124171     Medline TA:  Nat Rev Drug Discov     Country:  England    
Other Details:
Languages:  eng     Pagination:  795-6     Citation Subset:  IM    
Office of Translational Sciences, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland 20993, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  PPAR? is down-regulated following liver transplantation in mice.
Next Document:  Vemurafenib.